• Users Online: 351
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
CORRESPONDENCE
Year : 2016  |  Volume : 1  |  Issue : 3  |  Page : 149-151

Seven alternative opportunities to overcome the "Valley of Death" for CNS drug candidates developed by academic researchers


Department of Psychiatry and Neurosciences, Faculty of Medicine, Laval University, Quebec City, QC; Nordic Life Science Pipeline Inc., Quebec City, QC, Canada

Correspondence Address:
Pierre Guertin
Department of Psychiatry and Neurosciences, Faculty of Medicine, Laval University, Quebec City, QC; Nordic Life Science Pipeline Inc., Quebec City, QC
Canada
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2468-5577.187082

Rights and Permissions

The pharmaceutical industry has been facing tremendous challenges in recent years. Its Research & Development activities for innovation and drug development have significantly slowed down. Researchers in academic institutions often collaborate with pharmaceutical companies by providing them with new innovative products. However, the type of funding that they normally have access to does not ease drug development beyond discovery level. Here is a list of seven alternative opportunities that may help scientists, in North America, Europe and Asia, developing further their products and overcoming the so-called "Valley of Death". This may contribute bridging the gap between them and what Big Pharma is looking for, especially for the development of central nervous system products.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1168    
    Printed48    
    Emailed0    
    PDF Downloaded97    
    Comments [Add]    

Recommend this journal